Theracryf Plc

Theracryf Plcverified

TCF.L

Theracryf Plc, a clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioral brain disorders. The company's lead product is SFX-01 that is in Phase II clinical trials for the treatment of metastatic breast cancer; and in Phase I clinical trials for the treatment of neurodevelopmental disorders and glioblastoma, as well as in preclinical stage for the treatment of rhabdomyosarcoma. In addition, it engages in the development of orexin 1 antagonist, which is in late preclinical stage targeting addiction and anxiety; and atypical dopamine transporter inhibitor (DAT), which is in late preclinical stage targeting fatigue and narcolepsy. The company w...[Read more]

Industry

Biotechnology

IPO Date

2015-10-21

Stock Exchange

LSE

Ticker

TCF.L

The ROE as of December 2025 (TTM) for Theracryf Plc (TCF.L) is -44.95%

According to Theracryf Plc’s latest financial reports and current stock price. The company's current ROE is -44.95%. This represents a change of 7.60% compared to the average of -41.77% of the last 4 quarters.

Theracryf Plc (TCF.L) Historical ROE (quarterly & annually)

How has TCF.L ROE performed in the past?

The mean historical ROE of Theracryf Plc over the last ten years is -69.41%. The current -44.95% ROE has changed -35.25% with respect to the historical average. Over the past ten years (40 quarters), TCF.L's ROE was at its highest in in the March 2021 quarter at -7.04%. The ROE was at its lowest in in the September 2020 quarter at -72.16%.

Quarterly (TTM)
Annual

Average

-69.41%

Median

-66.73%

Minimum

-134.00%

Maximum

-22.64%

Theracryf Plc (TCF.L) ROE by Quarter and Year

Discovering the peaks and valleys of Theracryf Plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 155.85%

Maximum Annual ROE = -22.64%

Minimum Annual Increase = -75.73%

Minimum Annual ROE = -134.00%

Quarterly (TTM)
Annual
YearROEChange
2025-32.52%-75.73%
2024-134.00%77.02%
2023-75.70%155.85%
2022-29.59%30.69%
2021-22.64%-64.94%
2020-64.58%-48.91%
2019-126.40%89.42%
2018-66.73%-8.04%

Theracryf Plc (TCF.L) Average ROE

How has TCF.L ROE performed in the past?

The current ROE of Theracryf Plc (TCF.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-80.74%

5-year avg

-58.89%

10-year avg

-69.41%

Theracryf Plc (TCF.L) ROE vs. Peers

How is TCF.L’s ROE compared to its peers?

Theracryf Plc’s ROE is greater than CRISM Therapeutics Corporation (-79.01%), greater than Tissue Regenix Group plc (-2.38%), greater than Feedback plc (-83.25%), greater than Oxford BioDynamics Plc (-244.86%), greater than MyHealthChecked PLC (-30.82%), greater than N4 Pharma Plc (-91.34%), greater than Roquefort Therapeutics plc (-19.80%), less than Proteome Sciences plc (44.15%), greater than ValiRx plc (-46.92%), less than Chill Brands Group PLC (897.79%),

Build a custom stock screener for Theracryf Plc (TCF.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theracryf Plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Theracryf Plc (TCF.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Theracryf Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Theracryf Plc's ROE?

How is the ROE calculated for Theracryf Plc (TCF.L)?

What is the highest ROE for Theracryf Plc (TCF.L)?

What is the 3-year average ROE for Theracryf Plc (TCF.L)?

What is the 5-year average ROE for Theracryf Plc (TCF.L)?

How does the current ROE for Theracryf Plc (TCF.L) compare to its historical average?